Annals of Surgical Oncology

, Volume 5, Issue 4, pp 350–355 | Cite as

Hemangiopericytoma: A 20-year single-institution experience

  • Francis R. Spitz
  • Michael Bouvet
  • Peter W. T. Pisters
  • Raphael E. Pollock
  • Barry W. Feig
Original Articles


Background: Hemangiopericytoma is an uncommon soft tissue sarcoma. We sought to evaluate the long-term outcome of a consecutively treated patient cohort with hemangiopericytoma.

Methods: The study involved 36 adult patients (older than 16 years) with hemangiopericytoma treated at The University of Texas M. D. Anderson Cancer Center between July 1975 and July 1995. Data on clinicopathologic parameters, surgical treatment, adjuvant therapy, disease recurrence, and survival were obtained from a review of medical records.

Results: The median follow-up was 57 months. Twenty-eight patients (78%) underwent complete and potentially curative resection of their primary disease. Of the nine patients (32%) who had local recurrences, four (57%) had epidural tumors and three (43%) had retroperitoneal tumors, but none had extremity tumors. Extremity tumors were associated with a significantly prolonged local recurrence-free survival compared to tumors at nonextremity anatomic sites (P<.05). Ten patients had recurrences at distant sites. Of the 13 patients who experienced any form of disease recurrence, four had recurrences after a disease-free interval of more than 5 years. The 5-year actuarial survival rate for the entire group of 36 patients was 71%. Noncurative surgical treatment (P=.007) and development of distant metastatic disease (P=.013) were associated with shortened survival.

Conclusion: Extended survival is common in hemangiopericytoma patients treated with curative intent. However, local and distant recurrences may occur after a prolonged disease-free interval, emphasizing the need for long-term follow-up. Retroperitoneal and meningeal tumors were associated with higher local recurrence rates; therefore, adjuvant therapies should be considered and evaluated for tumors at these sites.

Key Words

Hemangiopericytoma Sarcoma Surgery Radiation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Stout AP, Murray MR. Hemangiopericytoma: vascular tumor featuring Zimmerman's pericytes.Ann Surg 1942;116:26–33.Google Scholar
  2. 2.
    Guthrie BL, Ebersolid MJ, Scheithauer BW, et al. Meningeal hemangiopericytoma: histopathological features, treatment and long-term follow-up of 44 cases.Neurosurgery 1989;25:514–22.PubMedGoogle Scholar
  3. 3.
    Ackerman LV, Warren S. Hemangiopericytoma of retroperitoneal space.J Mod Med Assoc 1948;45:380–2.Google Scholar
  4. 4.
    Croxatto JO, Fout RL. Hemangiopericytoma of the orbit: a clinicopathological study of 30 cases.Hum Pathol 1982;13:210–8.PubMedGoogle Scholar
  5. 5.
    Das AK, Gans BJ. Hemangiopericytoma of oral cavity: review of literature and report of a case.J Oral Surg 1965;23:456–60.PubMedGoogle Scholar
  6. 6.
    Gudrun R. Hemangiopericytoma in otolaryngology.J Laryngol Otol 1979;93:466–94.Google Scholar
  7. 7.
    Pitlyk PJ, Dockerty MB, Miller RH. Hemangiopericytoma of the spinal cord.Neurology 1965;15:649–53.PubMedGoogle Scholar
  8. 8.
    Poole RR, Barry JM, Carey TC. Hemangiopericytoma in male pelvis.Urology 1958;14:384–6.Google Scholar
  9. 9.
    Nappi O, Ritter JH, Pettinato G, Wick MR. Hemangiopericytoma: histopathologic pattern or clinicopathologic entity?Semin Diagn Pathol 1995;12:221–32.PubMedGoogle Scholar
  10. 10.
    Nunnery EW, Kahn LB, Reddick RL, Lipper SL. Hemangiopericytoma: a light microscopic and ultrastructural study.Cancer 1981;47:906–14.PubMedGoogle Scholar
  11. 11.
    Auguste LJ, Razack MS, Sako K. Hemangiopericytoma.J Surg Oncol 1982;20:260–4.PubMedGoogle Scholar
  12. 12.
    Daugaard S, Hultberg BM, Hou-Jensen K, Mouridsen HT. Clinical features of hemangiopericytomas and hemangioendotheliosarcomas.Acta Oncol 1988;27:209–13.PubMedGoogle Scholar
  13. 13.
    O'Brien P, Brasfield RD. Hemangiopericytoma.Cancer 1965;18:249–52.PubMedGoogle Scholar
  14. 14.
    Stout AP, Murray MR. Hemangiopericytoma.Am J Surg 1972;116:26–33.Google Scholar
  15. 15.
    Stout AP. Hemangiopericytoma.Cancer 1949;2:1027–35.PubMedGoogle Scholar
  16. 16.
    Enzinger FM, Smith BH. Hemangiopericytoma—an analysis of 106 cases.Hum Pathol 1976;7:61–82.PubMedGoogle Scholar
  17. 17.
    Fisher JH. Hemangiopericytoma: a review of twenty cases.Can Med Assoc J 1960;83:1136–9.PubMedGoogle Scholar
  18. 18.
    Pitluk HC, Conn J. Hemangiopericytoma: literature review and clinical presentations.Am J Surg 1979;137:413–6.CrossRefPubMedGoogle Scholar
  19. 19.
    Dube VE, Paulson JE. Metastatic hemangiopericytoma cured by radiotherapy.J Bone Joint Surg [Am] 1974;56:833–5.PubMedGoogle Scholar
  20. 20.
    Friedman M, Egan JW. Irradiation of hemangiopericytoma of Stout.Radiology 1960;74:721–30.PubMedGoogle Scholar
  21. 21.
    Mira JH, Chu FCH, Fortner JG. The role of radiotherapy in the management of malignant hemangiopericytoma: report of eleven new cases and review of literature.Cancer 1977;30:1254–9.Google Scholar
  22. 22.
    Lal H, Sanyal B, Paul GC, Rastogi BL, Khanna NN, Volupa KN. Hemangiopericytoma: report of three cases regarding role of radiation therapy.Am J Roentgenol 1976;126:887–91.Google Scholar
  23. 23.
    Jha N, McNeese M, Barkley HT, Kong J. Does radiotherapy have a role in hemangiopericytoma management? Report of 14 new cases and review of the literature.Int J Radiat Oncol Biol Phys 1987;13:1399–402.PubMedGoogle Scholar
  24. 24.
    Wong PP, Yagoda A. Chemotherapy of malignant hemangiopericytoma.Cancer 1978;41:1256–60.PubMedGoogle Scholar
  25. 25.
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations.J Am Stat Assoc 1958;53:457–81.Google Scholar
  26. 26.
    Pisters PWT, Brennan MF. Sarcomas of soft tissue. In: Abeloff M, Armitage J, Lichter A, Niederhuber J, eds.Clinical Oncology. New York: Churchill Livingstone, 1995:1799–1832.Google Scholar
  27. 27.
    Pisters PWT, Leung DHY, Woodruff J, Weiji S, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremity.J Clin Oncol 1996;14:1679–89.PubMedGoogle Scholar
  28. 28.
    McMaster MJ, Soule EH, Ivins JC. Hemangiopericytomas: a clinicopathologic study and long-term followup of 60 patients.Cancer 1975;36:2232–44.PubMedGoogle Scholar
  29. 29.
    Karpeh MS, Caldwell C, Gaynor JJ, Hajdu SI, Brennan MF. Vascular soft-tissue sarcomas: an analysis of tumor-related mortality.Arch Surg 1991;126:1474–81.PubMedGoogle Scholar
  30. 30.
    Brennan MF, Casper EF, Harrison LB, Shui MF, Gayner J, Hajdu SI. The role of multimodality therapy in soft-tissue sarcoma.Ann Surg 1991;214:2–10.Google Scholar
  31. 31.
    Tierney JF. A meta-analysis using individual patient data from randomized clinical trials of adjuvant chemotherapy for soft tissue sarcomas.Proceedings of the American Society of Clinical Oncology.Google Scholar

Copyright information

© The Society of Surgical Oncology, Inc. 1998

Authors and Affiliations

  • Francis R. Spitz
    • 1
  • Michael Bouvet
    • 1
  • Peter W. T. Pisters
    • 1
  • Raphael E. Pollock
    • 1
  • Barry W. Feig
    • 1
  1. 1.Dept. of Surgical OncologyThe University of Texas M. D. Anderson Cancer CenterHouston

Personalised recommendations